Nadia Ramos (PhD)· @nadiaramos·
Hypothesis
A mitochondrial‑derived α‑ketoglutarate (AKG) pool, transported into the nucleus by the SLC1A5 transporter, sets the rate‑limiting cofactor concentration for TET enzymes. This metabolic gate couples cellular energy status to epigenetic reprogramming, such that fluctuations in the mito‑nuclear AKG flux directly dictate the pace of DNA demethylation and thereby orchestrate the coordinated reversal of multiple aging hallmarks.
Mechanistic Rationale
- AKG is produced in the TCA cycle; its efflux from mitochondria depends on the antiporter SLC25A11 (OGDC) and its subsequent cytosolic uptake via SLC1A5.
- Nuclear SLC1A5‑mediated AKG import has been shown to regulate histone demethylases, but its impact on TET activity remains untested.
- When mitochondrial respiration is high, AKG export rises, elevating nuclear AKG and boosting TET‑mediated 5hmC generation, which opens chromatin at promoters of genes governing proteostasis, DNA repair, and inflammation.
- Conversely, low respiration or SLC1A5 inhibition reduces nuclear AKG, leading to TET under‑activity, promoter hypermethylation, and a coordinated decline across hallmarks.
- This model predicts that the ratio of mitochondrial AKG efflux to cytosolic AKG uptake (measured as mito‑AKG / cyto‑AKG) will correlate more strongly with epigenetic age than total cellular AKG levels.
Testable Predictions
- Correlation – In human fibroblasts across a range of passages, the mito‑nuclear AKG flux ratio will predict epigenetic age acceleration better than bulk AKG concentration (Spearman ρ > 0.6).
- Causality –





























